Arginase Deficiency Therapeutics Market was valued at USD 0.15 Billion in 2022 and is projected to reach USD 0.45 Billion by 2030, growing at a CAGR of 15% from 2024 to 2030.
Between 2018 and 2022, the Arginase Deficiency Therapeutics Market experienced notable developments. Arginase deficiency, a rare genetic disorder, affects approximately 1 in 300,000 to 1,000,000 individuals globally. During this period, increased awareness and advancements in diagnostic technologies led to earlier detection and intervention. However, challenges such as underdiagnosis persisted, making it difficult to determine the actual frequency of urea cycle disorders in the general population.
In terms of market valuation, the period saw a steady growth trajectory. The market was valued at USD 100 million in 2022, with projections indicating a rise to USD 136.8 million by 2030, reflecting a compound annual growth rate (CAGR) of approximately 4%. This growth was driven by technological advancements in treatment and diagnosis, as well as an increase in genetic inherited disorders. However, the market faced hurdles, including severe effects related to treatment, lack of etiology, and a low incidence rate, which may have hampered its expansion.
Looking ahead, from 2023 to 2033, the Arginase Deficiency Therapeutics Market is poised for further growth. The global market size is expected to reach USD 6.8 billion by 2024, with a projected CAGR of 11.2% from 2024 to 2032. Key drivers for this anticipated growth include:
Rising prevalence of arginase deficiency
Increasing awareness of the disease
Development of new and effective treatments
Geographically, major regions contributing to the market include North America, Europe, Asia Pacific, and the Rest of the World. Leading competitors in the market encompass BioMarin Pharmaceutical Inc., Ultragenyx Pharmaceutical Inc., and Amicus Therapeutics Inc.
Despite the optimistic outlook, the market faces challenges such as high treatment costs, lack of awareness, and limited treatment options. Opportunities lie in the development of new and effective treatments, increasing awareness of the disease, and a growing number of patients.
In my experience, the advancements in genetic research and the rising awareness among healthcare professionals have been pivotal in driving the market forward. The collaborative efforts between pharmaceutical companies, research institutions, and patient advocacy groups have significantly contributed to the development of novel treatments and therapies for arginase deficiency.
Get an In-Depth Research Analysis of the Global Arginase Deficiency Therapeutics Market Size And Forecast [2025-2032]
Helsinn Healthcare
Novartis Pharmaceuticals
Medicis Pharmaceutical
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Arginase Deficiency Therapeutics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Arginase Deficiency Therapeutics Market
Hospital
Drugs Stores
Other
Based on Types the Market is categorized into Below types that held the largest Arginase Deficiency Therapeutics market share In 2023.
Oral
Injection
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Arginase Deficiency Therapeutics Market Research Analysis
1. Introduction of the Global Arginase Deficiency Therapeutics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Arginase Deficiency Therapeutics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Arginase Deficiency Therapeutics Market, By Type
6. Global Arginase Deficiency Therapeutics Market, By Application
7. Global Arginase Deficiency Therapeutics Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Arginase Deficiency Therapeutics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/